Skip to content
healthcare.dev

Doxorubicin Hydrochloride

NDC 68001-493, Doxorubicin Hydrochloride, injectable, liposomal, from BluePoint Laboratories.

Product NDC
68001-493
Status
Listed
Labeler
BluePoint Laboratories
Dosage form
INJECTABLE, LIPOSOMAL
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203263
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68001-493 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXORUBICIN HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
68001-493-26680010493261 VIAL, SINGLE-DOSE in 1 PACKAGE (68001-493-26) / 25 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f6508535-e7a7-4e50-8d0c-43deda8d0d08
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=68001-493

Use it

Look up 68001-493 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68001-493 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68001-493. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.